Synmosa Biopharma (Taiwan) Probability of Future Stock Price Finishing Under 36.85
| 4114 Stock | TWD 34.05 0.35 1.02% |
Synmosa |
Synmosa Biopharma Target Price Odds to finish below 36.85
The tendency of Synmosa Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under NT$ 36.85 after 90 days |
| 34.05 | 90 days | 36.85 | about 50.78 |
Based on a normal probability distribution, the odds of Synmosa Biopharma to stay under NT$ 36.85 after 90 days from now is about 50.78 (This Synmosa Biopharma probability density function shows the probability of Synmosa Stock to fall within a particular range of prices over 90 days) . Probability of Synmosa Biopharma price to stay between its current price of NT$ 34.05 and NT$ 36.85 at the end of the 90-day period is about 50.87 .
Assuming the 90 days trading horizon Synmosa Biopharma has a beta of 0.17. This suggests as returns on the market go up, Synmosa Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Synmosa Biopharma will be expected to be much smaller as well. Additionally Synmosa Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Synmosa Biopharma Price Density |
| Price |
Predictive Modules for Synmosa Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Synmosa Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Synmosa Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Synmosa Biopharma is not an exception. The market had few large corrections towards the Synmosa Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Synmosa Biopharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Synmosa Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 1.01 | |
Ir | Information ratio | -0.36 |
Synmosa Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Synmosa Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Synmosa Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Synmosa Biopharma generated a negative expected return over the last 90 days | |
| About 25.0% of the company shares are owned by insiders or employees |
Synmosa Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Synmosa Stock often depends not only on the future outlook of the current and potential Synmosa Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Synmosa Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 297.3 M |
Synmosa Biopharma Technical Analysis
Synmosa Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. Synmosa Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Synmosa Biopharma. In general, you should focus on analyzing Synmosa Stock price patterns and their correlations with different microeconomic environments and drivers.
Synmosa Biopharma Predictive Forecast Models
Synmosa Biopharma's time-series forecasting models is one of many Synmosa Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Synmosa Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Synmosa Biopharma
Checking the ongoing alerts about Synmosa Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Synmosa Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Synmosa Biopharma generated a negative expected return over the last 90 days | |
| About 25.0% of the company shares are owned by insiders or employees |
Additional Tools for Synmosa Stock Analysis
When running Synmosa Biopharma's price analysis, check to measure Synmosa Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synmosa Biopharma is operating at the current time. Most of Synmosa Biopharma's value examination focuses on studying past and present price action to predict the probability of Synmosa Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synmosa Biopharma's price. Additionally, you may evaluate how the addition of Synmosa Biopharma to your portfolios can decrease your overall portfolio volatility.